148 related articles for article (PubMed ID: 8625292)
1. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.
Xu HJ; Zhou Y; Seigne J; Perng GS; Mixon M; Zhang C; Li J; Benedict WF; Hu SX
Cancer Res; 1996 May; 56(10):2245-9. PubMed ID: 8625292
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein.
Antelman D; Machemer T; Huyghe BG; Shepard HM; Maneval D; Johnson DE
Oncogene; 1995 Feb; 10(4):697-704. PubMed ID: 7862447
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells.
Zhang X; Multani AS; Zhou JH; Shay JW; McConkey D; Dong L; Kim CS; Rosser CJ; Pathak S; Benedict WF
Cancer Res; 2003 Feb; 63(4):760-5. PubMed ID: 12591722
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
[TBL] [Abstract][Full Text] [Related]
6. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
7. A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth.
Demers GW; Harris MP; Wen SF; Engler H; Nielsen LL; Maneval DC
Cancer Gene Ther; 1998; 5(4):207-14. PubMed ID: 9694072
[TBL] [Abstract][Full Text] [Related]
8. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
10. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
11. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.
Li J; Hu SX; Perng GS; Zhou Y; Xu K; Zhang C; Seigne J; Benedict WF; Xu HJ
Oncogene; 1996 Dec; 13(11):2379-86. PubMed ID: 8957079
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
13. [The retinoblastoma gene: from its basic understanding as a signal mediator for growth and differentiation to its use in the treatment of cancer].
Lee WH; Lee EY
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1368-80. PubMed ID: 9309128
[TBL] [Abstract][Full Text] [Related]
14. RB-mediated tumor suppression of a lung cancer cell line is abrogated by an extract enriched in extracellular matrix.
Kratzke RA; Shimizu E; Geradts J; Gerster JL; Segal S; Otterson GA; Kaye FJ
Cell Growth Differ; 1993 Aug; 4(8):629-35. PubMed ID: 8398904
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
[TBL] [Abstract][Full Text] [Related]
17. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
Shinoura N; Yoshida Y; Tsunoda R; Ohashi M; Zhang W; Asai A; Kirino T; Hamada H
Cancer Res; 1999 Jul; 59(14):3411-6. PubMed ID: 10416603
[TBL] [Abstract][Full Text] [Related]
18. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo.
Bass C; Cabrera G; Elgavish A; Robert B; Siegal GP; Anderson SC; Maneval DC; Curiel DT
Cancer Gene Ther; 1995 Jun; 2(2):97-104. PubMed ID: 7621262
[TBL] [Abstract][Full Text] [Related]
20. Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation.
Goodrich DW; Chen Y; Scully P; Lee WH
Cancer Res; 1992 Apr; 52(7):1968-73. PubMed ID: 1551125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
